Literature DB >> 31297509

Identification of expression signatures for non-small-cell lung carcinoma subtype classification.

Ran Su1, Jiahang Zhang1, Xiaofeng Liu2, Leyi Wei3.   

Abstract

MOTIVATION: Non-small-cell lung carcinoma (NSCLC) mainly consists of two subtypes: lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD). It has been reported that the genetic and epigenetic profiles vary strikingly between LUAD and LUSC in the process of tumorigenesis and development. Efficient and precise treatment can be made if subtypes can be identified correctly. Identification of discriminative expression signatures has been explored recently to aid the classification of NSCLC subtypes.
RESULTS: In this study, we designed a classification model integrating both mRNA and long non-coding RNA (lncRNA) expression data to effectively classify the subtypes of NSCLC. A gene selection algorithm, named WGRFE, was proposed to identify the most discriminative gene signatures within the recursive feature elimination (RFE) framework. GeneRank scores considering both expression level and correlation, together with the importance generated by classifiers were all taken into account to improve the selection performance. Moreover, a module-based initial filtering of the genes was performed to reduce the computation cost of RFE. We validated the proposed algorithm on The Cancer Genome Atlas (TCGA) dataset. The results demonstrate that the developed approach identified a small number of expression signatures for accurate subtype classification and particularly, we here for the first time show the potential role of LncRNA in building computational NSCLC subtype classification models.
AVAILABILITY AND IMPLEMENTATION: The R implementation for the proposed approach is available at https://github.com/RanSuLab/NSCLC-subtype-classification.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31297509     DOI: 10.1093/bioinformatics/btz557

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  7 in total

1.  An 8-Gene Signature for Classifying Major Subtypes of Non-Small-Cell Lung Cancer.

Authors:  Mehdi Hamaneh; Yi-Kuo Yu
Journal:  Cancer Inform       Date:  2022-06-14

2.  Detecting Interactive Gene Groups for Single-Cell RNA-Seq Data Based on Co-Expression Network Analysis and Subgraph Learning.

Authors:  Xiucai Ye; Weihang Zhang; Yasunori Futamura; Tetsuya Sakurai
Journal:  Cells       Date:  2020-08-21       Impact factor: 6.600

3.  A novel liver cancer diagnosis method based on patient similarity network and DenseGCN.

Authors:  Ge Zhang; Zhen Peng; Chaokun Yan; Jianlin Wang; Junwei Luo; Huimin Luo
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

4.  Observation on the Effect of High-Quality Nursing Intervention plus Health Education in Chemotherapy for Non-Small Cell Lung Cancer and Its Influence on the Physical and Mental Health of Patients.

Authors:  Liyun Feng; Dongmei Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-18       Impact factor: 2.650

5.  WERFE: A Gene Selection Algorithm Based on Recursive Feature Elimination and Ensemble Strategy.

Authors:  Qi Chen; Zhaopeng Meng; Ran Su
Journal:  Front Bioeng Biotechnol       Date:  2020-05-28

6.  Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.

Authors:  Xing Tang; Xiaopan Xu; Zhiping Han; Guoyan Bai; Hong Wang; Yang Liu; Peng Du; Zhengrong Liang; Jian Zhang; Hongbing Lu; Hong Yin
Journal:  Biomed Eng Online       Date:  2020-01-21       Impact factor: 2.819

7.  MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells.

Authors:  Hongqing Wen; Zhiyan Liu; Jingjing Tang; Lina Bu
Journal:  Aging (Albany NY)       Date:  2021-09-09       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.